Not applicableStudy completedNCT01056237What this trial is testingLong-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisWho this might be right forLupus Nephritis Zhi-Hong Liu, M.D. 206
Early research (Phase 1)WithdrawnNCT06984341What this trial is testingEvaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT07115745What this trial is testingHealthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesWho this might be right forRefractory Autoimmune Diseases Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Early research (Phase 1)Active Not RecruitingNCT06152172What this trial is testingCARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101Who this might be right forIdiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more David Porter 24
Not applicableLooking for participantsNCT07053891What this trial is testingLUPKYNIS Drug-use Results SurveyWho this might be right forLupus Nephritis Otsuka Pharmaceutical Co., Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT06121297What this trial is testingRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Cabaletta Bio 28
Early research (Phase 1)Looking for participantsNCT07629583What this trial is testingTo Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisWho this might be right forLupus Erythematosus, Systemic Genentech, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT03453619What this trial is testingPhase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesWho this might be right forIgA NephropathyLupus NephritisMembranous Nephropathy+2 more Apellis Pharmaceuticals, Inc. 21
Large-scale testing (Phase 3)Study completedNCT00282347What this trial is testingEvaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus NephritisWho this might be right forLupus Nephritis Genentech, Inc. 144
Large-scale testing (Phase 3)Study completedNCT03597464What this trial is testingAurinia Renal Assessments 2: Aurinia Renal Response in Lupus With VoclosporinWho this might be right forLupus Nephritis Aurinia Pharmaceuticals Inc. 216
Not applicableNot Yet RecruitingNCT07763821What this trial is testingClinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Who this might be right forSystem Lupus Erythematosus(SLE) Assiut University 128
Large-scale testing (Phase 3)UnknownNCT04892212What this trial is testingSirolimus in Treatment of Proteinuric Flares of Lupus NephritisWho this might be right forLupus NephritisImmunosuppressionEffect of Drug Peking Union Medical College Hospital 20
Not applicableUnknownNCT04320797What this trial is testingUrinary T Cell Biomarker for Prediction in Lupus NephritisWho this might be right forLupus Nephritis Charite University, Berlin, Germany 79
Testing effectiveness (Phase 2)Study completedNCT02260934What this trial is testingRituximab and Belimumab for Lupus NephritisWho this might be right forLupus Nephritis National Institute of Allergy and Infectious Diseases (NIAID) 43
Not applicableActive Not RecruitingNCT07823556What this trial is testingThe Role of Transforming Growth Factor- Beta (TGF- β) Expression in Renal Biopsy of Lupus Nephritis PatientsWho this might be right forLupus Nephritis (LN) Ain Shams University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07598396What this trial is testingEvaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisWho this might be right forLupusSystemic Lupus ErythematosusLupus Nephritis Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Looking for participantsNCT06947473What this trial is testingUmbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.Who this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)WithdrawnNCT06153095What this trial is testingIMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus ErythematosusLupus Nephritis Lyell Immunopharma, Inc.
Not applicableLooking for participantsNCT06796569What this trial is testingSystemic Immune Inflammatory Index in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Sohag University 90
Not applicableNot Yet RecruitingNCT07593911What this trial is testingEvaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune DiseasesWho this might be right forSystemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Multiple Sclerosis+3 more Beijing GoBroad Hospital 75